Investment
Features
FeesSafety
Academy
More
Pluang+

EnviroGold hires Dr. Greg O’Connor as Principal Metallurgist to boost project delivery and commercial rollout.

Company Fundamentals
30 Mar 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

EnviroGold Global Limited appointed Dr. Greg O’Connor as Principal Metallurgist to enhance project advancement and commercial deployment at its West Australian facility. With over 30 years of expertise in hydrometallurgy and process development, Dr. O’Connor will support EnviroGold's Rapid Deployment Pathway, aiming to convert technical results into viable commercial projects. This strategic hire strengthens the company’s capacity to accelerate project licensing, deployment, and revenue generation, aligning with its growth and clean technology goals in metal recovery from mine waste.

More News

Sodexo wins major global catering contract with Meta for 130+ sites in 30+ countries

Sodexo wins major global catering contract with Meta for 130+ sites in 30+ countries

Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...

Market News
Bullish
2 hours ago
Thor Explorations stays on track with gold production and strong cash position in Q2 2026.

Thor Explorations stays on track with gold production and strong cash position in Q2 2026.

Thor Explorations produced 19,153 ounces of gold in Q2 2026 from its Segilola mine in Nigeria, maintaining its full-year production guidance of 75,000 to 85,000 ounces. The company generated $77.3 million in revenue by selling 17,050 ounces at an ave...

Company Fundamentals
Bullish
4 hours ago
Angelini Pharma completes $4.1B acquisition of Catalyst, expanding US presence and brain health leadership.

Angelini Pharma completes $4.1B acquisition of Catalyst, expanding US presence and brain health leadership.

Angelini Pharma has finalized its $4.1 billion acquisition of Catalyst Pharmaceuticals, enhancing its footprint in the U.S. market and strengthening its global leadership in brain health and rare diseases. The deal includes significant investments fr...

Company Fundamentals
Bullish
4 hours ago
Greenwich LifeSciences' breast cancer drug shows strong Phase 2 results but faces funding risks ahead of Phase 3.

Greenwich LifeSciences' breast cancer drug shows strong Phase 2 results but faces funding risks ahead of Phase 3.

Greenwich LifeSciences is developing GLSI-100, an immunotherapy targeting HER2-positive breast cancer, currently in Phase 3 trials. The drug showed a 70-80% reduction in cancer recurrence in Phase 2b, outperforming existing treatments with no serious...

Analyst Insights
Bullish
4 hours ago
Ethereum breaks $1,900 resistance, fueled by strong buying and short liquidations

Ethereum breaks $1,900 resistance, fueled by strong buying and short liquidations

Ethereum (ETH) surged past the $1,894.89 resistance level, accelerating its recovery toward the $1,940–$1,950 zone after days of consolidation. This breakout was supported by lower-than-expected U.S. inflation data, which boosted risk appetite and bu...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App